Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency

Abstract Background Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that can result in a range of illnesses, with chronic obstructive pulmonary disease (COPD) being one of the most common. Although some people obtain genetic testing that identifies AATD, many people are unaware that they...

Bibliografske podrobnosti
Main Authors:	Ekin Seçinti, Karolina Schantz, Laure Delbecque, John Krege, Rikki Mangrum, Sarah E. Curtis
Format:	Article
Jezik:	English
Izdano:	BMC 2025-02-01
Serija:	Orphanet Journal of Rare Diseases
Teme:	Patient-reported outcome Measurement Literature review Alpha-1 antitrypsin deficiency
Online dostop:	https://doi.org/10.1186/s13023-025-03592-9

Podobne knjige/članki

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
od: Bebiana Conde, et al.
Izdano: (2022-07-01)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
od: Svetlana I. Melnik, et al.
Izdano: (2016-12-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
od: Chapman KR, et al.
Izdano: (2018-01-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
od: Dawid Kościołek, et al.
Izdano: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
od: Tobias Meischl, et al.
Izdano: (2023-01-01)

ALPHA-1-ANTITRYPSIN DEFICIENCY IN CHILDREN
od: S. I. MELNIK, et al.
Izdano: (2017-07-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
od: Mark Brantly, et al.
Izdano: (2020-04-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
od: Ilaria Ferrarotti, et al.
Izdano: (2024-02-01)

Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
od: Mohamed Shahat Badawy, et al.
Izdano: (2013-04-01)

Alpha1-antitrypsin deficiency and asthma
od: Emanuele Stirpe, et al.
Izdano: (2022-02-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
od: María Torres-Durán, et al.
Izdano: (2018-07-01)

Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
od: António Guilherme Murinello, et al.
Izdano: (2022-10-01)

Alpha-1-antitrypsin deficiency in children: Clinical characteristics and diagnosis
od: Radlović Nedeljko, et al.
Izdano: (2014-01-01)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
od: Herth FJF, et al.
Izdano: (2021-11-01)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
od: Sebastian Fähndrich, et al.
Izdano: (2017-09-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
od: Emanuel Buck, et al.
Izdano: (2022-01-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
od: Rodrigo Russo, et al.

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
od: Robert A. Stockley, et al.
Izdano: (2023-08-01)

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
od: Edgar RG, et al.
Izdano: (2017-05-01)

Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency
od: Daryl E. C. Y. Chan, et al.
Izdano: (2020-11-01)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
od: Annelot D. Sark, et al.
Izdano: (2022-02-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
od: Dunlea DM, et al.
Izdano: (2018-03-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
od: M. Yu. Pervakova, et al.
Izdano: (2016-12-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
od: Beiko T, et al.
Izdano: (2019-07-01)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
od: Barrecheguren M, et al.
Izdano: (2016-05-01)

Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review
od: Ramón A. Tubío-Pérez, et al.
Izdano: (2021-01-01)

Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease
od: De TOMMASO Adriana Maria Alves, et al.
Izdano: (2001-01-01)

Alpha-1 Antitrypsin Deficiency: Principles of Care
od: Joana F. Rodrigues, et al.
Izdano: (2020-06-01)

Testing Alpha-1 Antitrypsin Deficiency in Black Populations
od: Pascale Lafortune, et al.
Izdano: (2023-12-01)

Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
od: Seda Tural Onur, et al.
Izdano: (2022-01-01)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
od: Chorostowska-Wynimko J, et al.
Izdano: (2020-02-01)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
od: Nygren D, et al.
Izdano: (2022-06-01)

Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
od: Dilek Karadoğan, et al.
Izdano: (2024-12-01)

Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT
od: Laviña E, et al.
Izdano: (2024-02-01)

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
od: Paulo Henrique Ramos Feitosa, et al.
Izdano: (2024-12-01)

Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency – Related emphysema: Challenges and opportunities
od: L. Ross Pierce
Izdano: (2024-06-01)

Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency
od: Daniella A. Spittle, et al.
Izdano: (2023-07-01)

Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
od: Schramm GR, et al.
Izdano: (2025-03-01)

Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning
od: Daniela Zöller, et al.
Izdano: (2024-01-01)

Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential
od: Paulo Henrique Feitosa
Izdano: (2023-07-01)